Skip to main content
. 2023 Feb 28;28:e939149-1–e939149-9. doi: 10.12659/AOT.939149

Table 1.

Characteristics of the study participants as stratified by the serum cystatin C index.

Variables Group Cystatin C Statistic values P value
Normal (%) Abnormal (%)
Sex Male (n=162) 24 (14.8) 138 (85.2) 12.89** <0.001*
Female (n=53) 20 (37.7) 33 (62.3)
Age (Years) Youth (18~44) (n=165) 40 (21.6) 125 (78.4) 1.089** 0.297
Middle-aged (45~59) (n=70) 4 (13.3) 26 (86.7)
BMI Thin (<18.5) (n=26) 7 (26.9) 19 (73.1) 2.863** 0.239
Normal (18.5~24) (n=129) 29 (22.5) 100 (77.5)
Overweight (≥24) (n=60) 8 (13.3) 52 (86.7)
Smoking Never (n=157) 32 (20.4) 125 (79.6) 2.116** 0.351
Past (n=47) 8 (17.0) 39 (83.0)
Current (n=11) 4 (36.4) 7 (63.6)
Physical activity None (n=98) 18 (18.4) 80 (81.6) 0.487** 0.485
Yes (n=117) 26 (22.2) 91 (77.8)
Source of transplanted kidney Cadaver (n=34) 10 (29.4) 24 (70.6) 1.986** 0.159
Relatives (n=181) 34 (18.8) 147 (81.2)
Time after kidney transplantation (Months) n.a. 44 (20.5) 171 (79.5) −0.215*** 0.951
Pre-transplant dialysis Peritoneal dialysis (PD) (n=43) 9 (20.9) 34 (79.1) 0.009** 1.000
Hemodialysis (HD) (n=152) 31 (20.4) 121 (79.6)
None (n=20) 4 (20.0) 16 (80.0)
Drugs Tacrolimus treatment plan (n=155) 42 (26.5) 113 (73.5) 12.229** <0.001*
Cyclosporine treatment plan (n=60) 2 (5.0) 58 (95.0)
*

P<0.05;

**

χ2 value;

***

t value;

n.a. – not applicable.